Jan 26, 2009 | Laboratory Pathology, Management & Operations
Wall Street has yet to grasp this essential truth of laboratory medicine-lab test quality comes with its own price tag At this moment in time, Quest Diagnostics Incorporated’s (NYSE:DGX) advertised value proposition to other labs—”industry-leading quality and technical proficiency”—has diminished credibility with pathologists and lab industry executives. They are questioning how the nation’s largest lab company could allow systemic errors that caused it to report...
Nov 26, 2008 | Laboratory News, Laboratory Pathology
Aptly nicknamed “Dr. Germ,” Charles P. Gerba, Ph.D., a microbiologist at the University of Arizona in Tucson, Arizona, has made headlines recently with his list of the “10 Germiest Jobs in America.” Not surprisingly, lab scientist ranks number five. What job does Dr. Germ consider the germiest? Number one on his list was teachers and day care workers. Twice in the past month, network news reporters have interviewed Gerba. In October, NBC News highlighted his list of the...
Nov 17, 2008 | Instruments & Equipment, Laboratory Pathology
As healthcare becomes a global business, laboratory vendors from overseas are casting an envious eye on the market in the United States. After all, it is the world’s biggest and richest healthcare market, with more than $2 trillion in spending. Better yet, because healthcare in this country is organized around multiple payers and private providers, it provides competitive opportunities that don’t exist in many countries with single-payer health systems. Dark Daily has learned of a...
Oct 1, 2008 | Instruments & Equipment, Laboratory Pathology
As the nation’s healthcare system pursues the goal of a universal electronic medical record (EMR) and a paperless, all-electronic environment, one barrier to adoption may be the large number of physicians nearing retirement. That’s the opinion of a neurosurgeon in his recent testimony before a congressional committee. Physicians within five years of retirement may not get a return on their investment, Philip Tally, M.D., a neurosurgeon in Bradenton, Florida, told a hearing on...
